India joins Singapore and Indonesia in rush for vaccinations

New Delhi to deploy shots developed by Oxford-AstraZeneca and Bharat Biotech

20210106 India vaccine

A ground staffer at Indira Gandhi International Airport's Cargo Terminal 2, which will be used as a COVID-19 vaccine handling and distribution center, during a media preview in New Delhi on Dec. 22. © Reuters

KIRAN SHARMA, Nikkei staff writer

NEW DELHI -- India is ready to roll out two COVID-19 vaccines within 10 days of Jan. 3, when its drug regulator gave emergency use approval to the Oxford-AstraZeneca vaccine and a homegrown one from Bharat Biotech, the Health Ministry says.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.